Robins Kaplan LLP Announces 2020 Executive Board

March 2, 2020

Robins Kaplan LLP today announced the firm’s 2020 Executive Board.

The following partners have been re-elected to two-year board terms:

Jeffrey Gleason and David Martinez, Pro Bono Chair of the Los Angeles office, have been appointed to one-year board terms.

The following partners will continue to serve on the Executive Board:

  • Ronald Schutz, Chair of the Executive Board
  • Steven Schumeister, Managing Partner of the firm
  • Jake Holdreith, Leader, Health and Life Sciences Industry Group
  • Hollis Salzman, Managing Partner of the New York office and Co-Chair of the Antitrust and Trade Regulation Group

Related Publications

Second Quarter
ANDA Litigation Settlements
GENERICally Speaking Summer 2021
Second Quarter
New ANDA Cases
GENERICally Speaking Spring 2021
Second Quarter
ANDA Approvals
GENERICally Speaking Summer 2021
Second Quarter
Generic Launches
GENERICally Speaking Summer 2021
July 15, 2021
Biotechnology & Trade Secret Protection
Sharon Roberg-Perez, David Prange, Ellen Levish - Bloomberg Law
Back to Top